Skip to main content
. Author manuscript; available in PMC: 2018 Mar 26.
Published in final edited form as: Virol Sin. 2017 Oct 10;32(5):369–375. doi: 10.1007/s12250-017-4027-2

Figure 1.

Figure 1

Targeting sphingolipid metabolism in KSHV-infected host cells. CerS, ceramide synthase; S1PP, S1P phosphatase; SphKs, sphingosine kinases; S1PRs, S1P receptors. ABC294640: A novel selective SPHK2 inhibitor; C6-Cer, dhC16-Cer etc: exogenous short- or long-chain ceramides.